Work

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

Year: 2019

Type: article

Study design: Clinical Trial

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-019-03243-7

Authors: Thomas J. Kaley, Katherine S. Panageas, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa M. DeAngelis, Lauren E. Abrey, Eric C. Holland, Andrew B. Lassman

Institutions: Memorial Sloan Kettering Cancer Center, Novartis (Switzerland), University of Washington, Fred Hutch Cancer Center, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G3606306859, Cancer Center Support Grant

OpenAlex ID: W2963868337

FWCI: 4.048

Cites: 22

Cited by: 60

Related to: 10